Kidney disease doesn't look the same for everyone. The National Kidney Foundation identifies five stages based on how well your kidneys filter waste, measured by something called glomerular filtration rate (GFR). Think of GFR as a percentage score—the higher the number, the better your kidneys are working. Someone in stage 1 might have a GFR above 90, meaning their kidneys are filtering nearly normally but may show signs of damage. By stage 5, the GFR drops below 15, meaning the kidneys are filtering very little waste from the blood.
Learn About Paying Your FGUA Bill Online →
This staging system matters because it determines which treatments make sense at each point. Early-stage kidney disease (stages 1-2) focuses heavily on slowing progression through medication and lifestyle changes. You might never need dialysis or transplant. Middle stages (3-4) introduce more intensive monitoring and preparation for what comes next. Stage 5 is when kidney replacement therapy—dialysis or transplant—becomes necessary to stay alive.
The cause of kidney disease also shapes treatment. Someone whose kidneys are damaged by diabetes needs different management than someone with high blood pressure or an inherited condition like polycystic kidney disease. A nephrologist (kidney specialist) considers your stage, your cause, your overall health, and your preferences when recommending a path forward.
One practical takeaway: if you've been told you have kidney disease, understanding your stage and cause is the foundation. These two pieces of information determine what treatment options actually apply to your situation. Ask your doctor for both your stage and the underlying cause—this conversation is where personalized treatment planning actually begins.
The most common starting point for treating kidney disease is medication—specifically drugs that protect the kidneys from further damage. Two classes of medications do this particularly well: ACE inhibitors and ARBs (angiotensin II receptor blockers). Both work similarly by relaxing blood vessel walls and reducing pressure inside the kidneys. Studies show they can slow the decline in kidney function, sometimes by several years. Examples include lisinopril, enalapril (ACE inhibitors), and losartan, valsartan (ARBs).
Free Guide to Pay by Plate Illinois Billing →
If you have diabetes and kidney disease, these medications are often prescribed early because they offer dual protection—controlling blood pressure while specifically protecting kidney tissue. A 2019 analysis in the Journal of the American Society of Nephrology found that ACE inhibitors reduced progression to kidney failure by about 20 percent in people with diabetes.
A newer medication class called SGLT2 inhibitors (sodium-glucose cotransporter-2 inhibitors) has emerged as game-changing. Originally developed for diabetes, drugs like empagliflozin and dapagliflozin have shown remarkable results in slowing kidney disease even in non-diabetic patients. The DAPA-CKD trial, published in 2020, showed these medications reduced the risk of kidney disease progression or death by 39 percent compared to placebo.
Your doctor might also prescribe a statin (for cholesterol), blood pressure medications beyond ACE inhibitors or ARBs, and medications to manage anemia or bone health as kidney function declines. Phosphate binders help when phosphorus builds up in the blood. Each medication targets a specific problem created by failing kidneys.
Practical takeaway: early medication use is how most people with kidney disease delay or prevent reaching stage 5. The conversation with your doctor should focus on which medications target your specific situation. If a medication isn't working or causes side effects, alternatives exist—persistence in finding the right regimen often pays off in years gained.
When kidneys fail to the point where medication alone isn't enough, dialysis enters the picture. Dialysis is a process that mimics what healthy kidneys do—remove waste and excess fluid from the blood. About 468,000 Americans currently use dialysis, according to the United States Renal Data System, making it one of the most common kidney disease treatments for stage 5.
Free Guide to Mold Removal Methods for Walls →
There are two main types of dialysis: hemodialysis and peritoneal dialysis. Hemodialysis is the more familiar image—a patient sits in a reclining chair while a machine filters their blood through an artificial kidney. The process typically happens three times a week for three to five hours per session. A surgeon creates access to your blood vessels, usually in your arm, making it easier for needles to draw blood into the machine. The artificial kidney (called a dialyzer) has a special membrane that lets waste and excess water pass through while keeping blood cells and proteins in the bloodstream. Blood returns to your body cleaned and filtered.
Peritoneal dialysis works differently. Instead of a machine, the treatment uses the peritoneum—a thin membrane lining your abdomen. A surgeon places a soft catheter into your belly, and you infuse dialysate (a special fluid) into your abdominal cavity. Waste from your blood passes through the peritoneum into the dialysate, which you then drain out. This can happen multiple times daily in what's called continuous ambulatory peritoneal dialysis (CAPD), or at night using a machine in automated peritoneal dialysis (APD).
Each type has tradeoffs. Hemodialysis requires going to a center but gives you days off from treatment. Peritoneal dialysis offers more flexibility and independence but requires discipline with sterile technique to avoid infection. Insurance generally covers both, though coverage specifics vary.
Practical takeaway: if dialysis becomes necessary, you have choices about how it happens. Spending time understanding both options—visiting a dialysis center, talking to people on peritoneal dialysis, asking your nephrologist about your personal fit—makes this major life decision less overwhelming and more grounded in reality.
For many people with stage 5 kidney disease, a kidney transplant offers the best long-term quality of life. A working transplanted kidney filters waste like a natural kidney, eliminating the need for dialysis three days a week. About 23,000 kidney transplants happen annually in the United States, and people with transplants report better energy levels, fewer dietary restrictions, and greater freedom in their daily lives.
How to Delete Your Fitbit Account Guide →
Kidneys come from two sources: a living donor (often a family member, friend, or altruistic stranger) or a deceased donor. Living donor transplants have a major advantage—you can schedule the surgery in advance, and kidneys from living donors typically function longer than deceased donor kidneys. The median lifespan of a living donor kidney is 15-20 years; a deceased donor kidney averages 10-15 years. This difference exists partly because living donor surgery can happen sooner, before the transplant recipient's health declines further.
The transplant procedure itself involves placing a new kidney in your lower abdomen while leaving your original non-functioning kidneys in place (removal isn't usually necessary). Surgeons connect the new kidney's blood vessels to your blood vessels and attach the ureter—the tube that carries urine—to your bladder. Recovery takes several weeks, but most people feel dramatically better once the new kidney is working.
The catch: transplant recipients must take immunosuppressant medications for life. These drugs prevent your immune system from attacking the new kidney as a foreign object. Medications like tacrolimus, mycophenolate, and prednisone must be taken consistently. Miss doses or stop taking them, and your body will reject the kidney. Managing these medications, attending frequent follow-up appointments, and monitoring for side effects becomes your new routine.
Access to transplant isn't equal. You must meet medical criteria (being healthy enough to survive surgery), find a donor, and navigate a matching system. About 90,000 people are on the waiting list for a deceased donor kidney, with average wait times between 3-7 years depending on your blood type and tissue compatibility. Living donor transplants bypass this wait.
Practical takeaway: if you're in stage 4 or early stage 5, asking your nephrologist about transplant makes sense even if it seems far away. Getting evaluated early, exploring living donor options with family or friends, and understanding the realistic timeline helps you make decisions from a position of knowledge rather than crisis.
Not everyone with stage 5
This guide is for general information only and is not medical, financial, legal, or other professional advice. For decisions specific to your situation, consult a qualified professional. See our Editorial Policy.